Redwood Pharma AB

Redwood Pharma is a pharmaceutical company. The main focus is on the production of ophthalmic pharmaceuticals. The products contain active substances that are used in the treatment of dry eye disease (DED), characterised by dryness, pain, and burning. The disorder is caused by inflammation due to dysfunction of the glands as well as by the usage of contact lenses. The company is based in Stockholm.

Quotes

Board

CEO

  • Martin Vidaeus

Chairperson of the Board

  • Gunnar Mattsson

Board

  • Hans Ageland
  • Ingrid Atteryd-Heiman
  • Martin Vidaeus
  • Mats Lidgard

Videos

1 / 4
Interview Redwood Pharma - Om de lyckade resultaten för RP101 och vägen framåt
Interview Redwood Pharma announces the results from Phase 2 trials
CompanyPresentation Redwood Pharma intervju på Biostock Live
CompanyPresentation Redwood Pharma company presentation at BioStock Live
*Powered by Modular Finance